IL1B and lip and oral cavity carcinoma: IL-1R1 promotes oral cancer growth and metastasis by upregulating CXCR4 (a chemokine receptor involved in tumor progression, angiogenesis and metastasis) after IL-1β stimulation, and IL-1R1 inhibition with recombinant IL-1RA has shown to reverse these effects [66].